Ludwig, H
Weisel, K
Petrucci, M T
Leleu, X
Cafro, A M
Garderet, L
Leitgeb, C
Foa, R
Greil, R
Yakoub-Agha, I
Zboralski, D
Vauléon, S
Dümmler, T
Beyer, D
Kruschinski, A
Riecke, K
Baumann, M
Engelhardt, M
Article History
First Online: 11 January 2017
Competing interests
: HL declares receiving honoraria from advisory boards from Amgen, Celgene, BMS and for speakers bureau from Cilag-Janssen, Celgene, Amgen and BMS, and research support from Takeda. MTP received honoraria from Celgene, Janssen-Cilag, Amgen, BMS and Mundipharma. RF is on advisory boards and/or speakers bureau for Janssen, Roche, Genentech, Gilead, Amgen, Pfizer, Sandoz and BMS. KR, AK, SV, TD, DZ and DB are employees and MB is a board member of NOXXON Pharma AG. The remaining authors declare no conflict of interest.